18 Investor presentation First six months of 2025 Strategic aspirations 2025 Purpose and sustainability (ESG) • Progress towards zero environmental impact • Being respected for adding value to society • Being recognised as a sustainable employer • Strengthen Diabetes leadership - aim at global value market share of more than 1/3 • More than 25 billion DKK in Obesity sales by 2025 • Secure a sustained growth outlook for Rare disease Note: The strategic aspirations are not a projection of Novo Nordisk's financial outlook or expected growth. Commercial execution
Download PDF file